Medpace Holdings, Inc. (MEDP)
Healthcare • Diagnostics & Research
StockNasdaqGSUnited StatesUS58506Q1094
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Medpace Holdings, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 16:27. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 08 Feb 2027 16:00 | 4.88 | — | — | Upcoming |
| 21 Oct 2026 16:00 | 4.46 | 4.84 | +8.5% | Beat |
| 22 Jul 2026 16:00 | 4.00 | 4.25 | +6.2% | Beat |
| 22 Apr 2026 16:00 | 3.96 | 4.28 | +8.2% | Beat |
| 09 Feb 2026 16:00 | 4.23 | 4.67 | +10.5% | Beat |
| 22 Oct 2025 16:00 | 3.57 | 3.86 | +8.1% | Beat |
| 21 Jul 2025 16:00 | 3.00 | 3.10 | +3.5% | Beat |
| 21 Apr 2025 16:00 | 3.07 | 3.67 | +19.6% | Beat |
| 10 Feb 2025 16:00 | 3.12 | 3.68 | +18.1% | Beat |
| 21 Oct 2024 16:00 | 2.87 | 3.01 | +5.2% | Beat |
| 22 Jul 2024 16:00 | 2.63 | 2.76 | +5.2% | Beat |
| 22 Apr 2024 16:00 | 2.49 | 3.22 | +29.2% | Beat |
| 12 Feb 2024 16:00 | 2.52 | 2.48 | -1.8% | Miss |
| 23 Oct 2023 16:00 | 2.19 | 2.24 | +2.1% | Beat |
| 24 Jul 2023 16:00 | 2.00 | 1.95 | -2.4% | Miss |
| 24 Apr 2023 16:00 | 1.88 | 2.28 | +21.5% | Beat |
| 13 Feb 2023 16:00 | 1.87 | 2.14 | +14.3% | Beat |
| 24 Oct 2022 16:00 | 1.54 | 2.07 | +34.2% | Beat |
| 25 Jul 2022 16:00 | 1.39 | 1.48 | +7.2% | Beat |
| 25 Apr 2022 16:00 | 1.31 | 1.71 | +30.4% | Beat |
| 14 Feb 2022 16:00 | 1.29 | 1.36 | +4.9% | Beat |
| 25 Oct 2021 16:00 | 1.12 | 1.32 | +17.9% | Beat |
| 26 Jul 2021 16:00 | 1.03 | 1.09 | +5.9% | Beat |
| 26 Apr 2021 16:00 | 1.07 | 1.18 | +9.7% | Beat |
| 15 Feb 2021 16:00 | 1.31 | 1.40 | +7.1% | Beat |
| 26 Oct 2020 16:00 | 1.16 | 1.14 | -1.1% | Miss |
| 27 Jul 2020 16:00 | 0.44 | 0.68 | +54.3% | Beat |
| 28 Apr 2020 17:00 | 0.76 | 0.80 | +6.0% | Beat |
| 24 Feb 2020 16:00 | 0.75 | 0.85 | +12.7% | Beat |
| 28 Oct 2019 16:00 | 0.71 | 0.71 | -0.5% | In line |
| 29 Jul 2019 16:00 | 0.64 | 0.81 | +27.6% | Beat |
| 29 Apr 2019 16:00 | 0.61 | 0.64 | +5.3% | Beat |
| 25 Feb 2019 16:00 | 0.69 | 0.75 | +8.9% | Beat |
| 29 Oct 2018 16:00 | 0.63 | 0.67 | +6.6% | Beat |
| 30 Jul 2018 16:00 | 0.43 | 0.61 | +41.2% | Beat |
| 30 Apr 2018 16:00 | 0.44 | 0.55 | +26.2% | Beat |
| 26 Feb 2018 16:00 | 0.38 | 0.39 | +1.4% | Beat |
| 30 Oct 2017 16:00 | 0.36 | 0.40 | +12.0% | Beat |
| 31 Jul 2017 16:00 | 0.30 | 0.38 | +27.2% | Beat |
| 01 May 2017 17:00 | 0.37 | 0.34 | -8.6% | Miss |
| 27 Feb 2017 16:00 | 0.34 | 0.35 | +3.1% | Beat |
| 03 Nov 2016 16:00 | 0.34 | 0.40 | +17.1% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 2.5B | +20.0% | 451.1M | 17.8% | 15.28 | +21.0% | 681.9M |
| 2024 | 2.1B | +11.8% | 404.4M | 19.2% | 12.63 | +42.2% | 572.3M |
| 2023 | 1.9B | +29.2% | 282.8M | 15.0% | 8.88 | +22.0% | 396.7M |
| 2022 | 1.5B | — | 245.4M | 16.8% | 7.28 | — | 351.2M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 649.06 | 679.18 | 632.11 | 647.55 | -0.68% | 1,892,451 | |
| Oct 2026 | 627.47 | 693.97 | 587.39 | 652.01 | +4.46% | 7,200,700 | |
| Sep 2026 | 595.52 | 637.65 | 577.64 | 624.18 | +5.08% | 4,981,700 | |
| Aug 2026 | 588.07 | 629.69 | 563.45 | 593.99 | +2.92% | 4,344,200 | |
| Jul 2026 | 546.51 | 677.90 | 514.47 | 577.11 | +8.97% | 8,597,700 | |
| Jun 2026 | 446.43 | 540.00 | 434.38 | 529.59 | +18.45% | 6,430,400 | |
| May 2026 | 420.00 | 453.54 | 403.46 | 447.11 | +6.80% | 6,666,800 | |
| Apr 2026 | 480.30 | 530.97 | 373.00 | 418.66 | -12.81% | 10,200,500 | |
| Mar 2026 | 444.98 | 483.30 | 441.85 | 480.19 | +6.29% | 6,842,100 | |
| Feb 2026 | 576.16 | 597.88 | 392.35 | 451.76 | -22.44% | 9,667,000 | |
| 51 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- 3 Reasons Why Growth Investors Shouldn't Overlook Medpace (MEDP) (opens in a new tab) Zacks · 11 Nov 2026 16:45
- If You Invested $1000 in Medpace a Decade Ago, This is How Much It'd Be Worth Now (opens in a new tab) Zacks · 06 Nov 2026 12:30
- Did Earnings Beat Just Shift Medpace Holdings (MEDP) Investment Narrative? (opens in a new tab) Simply Wall St. · 05 Nov 2026 08:15
- CON vs. MEDP: Which Stock Is the Better Value Option? (opens in a new tab) Zacks · 02 Nov 2026 15:40
- Medpace (MEDP) is a Great Momentum Stock: Should You Buy? (opens in a new tab) Zacks · 30 Oct 2026 15:00
- Medpace Holdings, Inc. (MEDP) Hits Fresh High: Is There Still Room to Run? (opens in a new tab) Zacks · 29 Oct 2026 12:15
- Breakout Watch: 4 Reasons To Monitor This Top-Rated Medical Stock (opens in a new tab) Investor's Business Daily · 28 Oct 2026 19:13
- Is Medpace (MEDP) a Solid Growth Stock? 3 Reasons to Think "Yes" (opens in a new tab) Zacks · 26 Oct 2026 15:45
- All You Need to Know About Medpace (MEDP) Rating Upgrade to Buy (opens in a new tab) Zacks · 26 Oct 2026 15:00
- MEDP Q3 deep dive: bookings strength drives growth, margin expansion continues (opens in a new tab) StockStory · 24 Oct 2026 00:20
- 5 revealing analyst questions from Medpace’s Q3 earnings call (opens in a new tab) StockStory · 23 Oct 2026 12:12
- Does Medpace Holdings (MEDP) Leave Any Room For Cash Flow Upside? (opens in a new tab) Simply Wall St. · 23 Oct 2026 07:17
- Medpace: 3 Key Takeaways for Long-Term Investors (opens in a new tab) Motley Fool · 23 Oct 2026 05:11
- Medpace Holdings (MEDP) Beat Q3 Estimates, Is It Still 24% Overvalued? (opens in a new tab) Simply Wall St. · 22 Oct 2026 23:10
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 656.84 USD
- Market cap
- 18.4B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow MEDP and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.